• Is Ketamine on a Standard Drug Test?
• When Ketamine Will Be Detected (Specialty Testing)
• Ketamine’s Detection Window (How Long It Stays)
• How Ketamine Therapy Patients Can Avoid Drug Testing Problems
• FAQs About Drug Testing for Ketamine
  

Standard 5-panel and 10/12-panel drug tests do not typically screen for ketamine. However, detection can occur in rare cases when an employer, clinic, or legal entity specifically orders a specialized or expanded toxicology panel that includes ketamine as an analyte. 

Given ketamine’s increasing use in mental health clinics, it makes sense to wonder whether it will show up on drug tests. 

This guide will walk you through when ketamine detection is likely and how to prevent complications with your employer or testing agency.

Is Ketamine on a Standard Drug Test?

Ketamine and its byproducts, like norketamine & 5,6-dehydronorketamine (5,6-DHNK), do not appear on standard drug screens, which include 5-panel tests, 10-panel tests, and 12-panel tests. There may be several reasons for this:

• Ketamine is a legitimate FDA-approved drug for anesthesia and a evidence-based off-label treatment for depression and other mental disorders. 
• The body metabolizes ketamine quickly, so it’s harder to detect with standard tests.
• Specialized tests required to screen for ketamine are costly.  

The 5-Panel Test: Standard Workplace Screening

The 5-panel drug test is the most common form of private and public workplace and government-mandated screening in the United States, including tests regulated by the Department of Transportation (DOT). This panel is designed to detect the presence of the most commonly misused illegal and high-risk substances.

What the 5-Panel Screens For (The “Federal Five”)

The standard 5-panel test, often called the “Federal Five” or SAMHSA-5 (Substance Abuse and Mental Health Services Administration), does not screen for ketamine.

This panel is strictly limited to the following five drug classes:

1. Marijuana (THC): Screens for THC metabolites, the psychoactive component of cannabis.

2. Cocaine: Screens for the primary metabolite, benzoylecgonine.

3. Amphetamines/Methamphetamines: Includes amphetamine, methamphetamine, and often ecstasy (MDMA).

4. Opioids/Opiates: Screens for natural opiates (Codeine, Morphine, Heroin), semi-synthetic opioids (Hydrocodone, Oxycodone, etc.), and synthetic opioids (fentanyl – effective July 2025 in federal drug screens) 

5. Phencyclidine (PCP): A dissociative hallucinogen, commonly known as “angel dust.”

If an employer requires a ketamine test, they must specifically request a customized screen.

The 10- and 12-Panel Tests: Broader Screening

When an employer or organization requires a more comprehensive drug screen than the standard 5-panel test, they may order a 10-panel or 12-panel test. These tests may occur in high-security roles, some healthcare and financial settings, and judicial or compliance programs (like probation).

The fundamental takeaway remains the same: Ketamine is not a standard substance included in off-the-shelf 10- or 12-panel drug tests.

What a 10- and 12-Panel Typically Includes

These expanded panels include the five core substances (THC, Cocaine, Amphetamines, Opioids, and PCP). They also broaden the screening to include five to seven additional classes of commonly misused prescription and illicit drugs.

A typical 10- or 12-panel screen includes:

Category	Common Examples Screened For
The Federal Five	THC, Cocaine, Amphetamines, PCP, and Opioids (Codeine, Morphine, Heroin)
Benzodiazepines	Xanax, Valium, Klonopin, Ativan
Barbiturates	Phenobarbital, Secobarbital
Methadone	Medication for opioid addiction treatment
Propoxyphene	Darvon (though largely discontinued)
Methaqualone	Quaaludes (largely historical)
Expanded Opioids/Oxycodones	Oxycodone (OxyContin, Percocet), Hydrocodone, Demerol, Tramadol
MDMA/Ecstasy	Added to the 12-panel in some configurations

The only way ketamine will be detected on a test ordered as a “10-panel” or “12-panel” is if the ordering party customizes the request to include it. This is far more likely in specialty settings.

When Ketamine Will Be Detected (Specialty Testing)

Ketamine will only be detected on a drug test if the organization or provider specifically orders a custom toxicology panel that includes ketamine as an analyte (often listed as KET).

These tests are reserved for scenarios where there is a clear medical, legal, or safety-sensitive reason to monitor the patient for ketamine use or misuse.

Pain Management Programs 

Clinics providing controlled substances or administering ketamine therapy itself are the most common places for specialized testing:

Treatment Adherence: Many pain management or chronic care programs require regular urine drug testing (UDT) to ensure the patient is taking their prescribed medication and not taking non-prescribed or illicit substances. Ketamine may be added explicitly to these panels if the patient is receiving ketamine as part of their regimen or if the provider suspects the patient is veering off the protocol.

Substance-Use Disorder Treatment: Individuals in addiction recovery programs are often tested intermittently and comprehensively for a wide range of substances, which may include ketamine.

Hospital & Emergency Toxicology 

In emergencies, doctors may order a comprehensive toxicology screen to diagnose the cause of unexplained symptoms, such as:

Altered Mental Status: If a patient enters the Emergency Department with confusion, dissociation, or hallucinations.

Overdose Suspicion: To determine the precise substances ingested during a suspected overdose or poisoning.

Medical Complications: To investigate severe symptoms like respiratory distress, cardiac failure, or ketamine-related urinary issues (“ketamine bladder”).

Legal & Probation Evaluations

Forensic investigations, probation offices, and courts may use highly extended toxicology screens where ketamine is relevant to the case.

Forensic Investigations: Cases involving impaired driving, road traffic accidents, or criminal investigations often use definitive testing methods (GC-MS or LC-MS/MS) that include ketamine.

Court or Probation: Standard 5- or 10-panel tests are common for probation. However, a judge or parole officer can order a customized toxicology screen that adds ketamine if it is relevant to the case.

Child Custody or Family Law: Specialized long-term tests, like hair follicle or fingernail tests, which can detect use over several months, may be ordered in child custody disputes when misuse is suspected.

Specialized Federal/State Safety Roles

Detection is more likely in roles where the testing objective is fitness for duty (FFD) or national security. Testing protocols for these positions are often more comprehensive than the DOT’s minimum requirements.

Nuclear Regulatory Commission (NRC) FFD: The NRC can order expanded testing for ketamine if its presence, even as a prescribed drug, is found to violate the objective of safe and competent performance of duties.

DOD Contractors and Security Clearance: High-security federal environments and DOD contractors may reserve the right to conduct comprehensive, expanded fitness evaluations that include Schedule III drugs, such as ketamine.

State and Local Law Enforcement/First Responders: State and local agencies are not bound by DOT rules and may utilize expanded toxicology screens based on their discretion.

Ketamine’s Detection Window (How Long It Stays)

Ketamine’s detection window in specialized drug tests depends heavily on the type of specimen used (e.g., urine, blood), the dosage ingested, frequency of use, and the person’s metabolism. The compound can stay in the system for mere hours or linger for weeks or months. 

Urine (Most Common Test)

Urine is the most common specimen used for drug screening because it is non-invasive and provides a moderately long detection window.

• Single Ketamine Use: Specialized lab toxicology tests can detect a single ketamine infusion dose for 2 to 14 days after administration. 
• Chronic/Frequent Use: Chronic ketamine use can extend the detection to more than a week or much longer – 22 to 96 days.
  
• What is Detected: Urine tests primarily detect ketamine’s main inactive metabolite, norketamine, which is chemically distinct from the parent drug. They also examine minor metabolites, such as dehydronorketamine, hydroxyketamines, and hydroxynorketamines.

Blood (Acute Detection)

Blood testing is invasive and expensive, so employers rarely use it for workplace screening. Acute medical or forensic settings (like emergency rooms or accident investigations) are most likely to examine blood.

• Detection Window: Only a few hours (typically 4–8 hours), but may remain up to 24 hours.
  
• Why It’s Short: Ketamine is rapidly metabolized by the liver into norketamine, which quickly clears the parent drug from the bloodstream.
  
• Exception: Blood tests that screen for ketamine’s longest-lasting metabolite, 5,6-DHNK, can detect it in plasma for 6 to 10 days. 

Saliva/Oral Fluid (Short-Term)

Saliva testing is a non-invasive and easy-to-administer method. Roadside testing facilities or specific workplace environments with immediate suspicion may utilize this screening method.

• Detection Window: Ketamine is mostly undetectable in saliva within 4 to 6 hours post-administration. However, it may last up to 24 to 48 hours.
  
• What is Detected: Saliva detects the parent drug (ketamine) present in the oral cavity and blood plasma, indicating very recent use.
  
• Exception: Saliva test that screens for ketamine’s longest-lasting metabolite, 5,6-DHNK, can detect it in plasma for 6 to 10 days. 

Hair (Longest Window)

Hair follicle testing is the most expensive and least common method for workplace screening, but it provides the longest historical detection window.

• Detection Window: Up to 4 months or longer, depending on the length of the hair sample taken.
  
• How It Works: The standard sample analyzes 90 to 120 strands cut from the scalp, representing approximately 3 months of use.
  
• Frequency: Hair tests typically occur in legal, forensic, or sensitive security evaluations where establishing a history of use is critical.

How Ketamine Therapy Patients Can Avoid Drug Testing Problems

If you are undergoing ketamine therapy (IV infusion, Spravato, or prescribed oral/sublingual/spray forms) and have an upcoming drug screen, you may want to take proactive steps to protect yourself.

Ask Which Substances the Test Includes

Consider asking your employer or the testing organization for documentation specifying the type of panel being used (e.g., “5-panel,” “10-panel,” “expanded opioid panel”).

Specifically ask if ketamine is one of the analytes. If it is a standard employment test, the answer will almost certainly be no.

Notify the Tester or Medical Review Officer (MRO) Beforehand

Consider informing the collection site administrator that you are taking a legally prescribed, Schedule III controlled substance. They do not need to know the specific drug, but they must be notified that the results may require review.

The medical review officer (MRO)—the independent physician reviewing the results—will contact you confidentially if the drug test yields screens positive for ketamine. If you have not already done so, this is a critical opportunity to provide documentation. The MRO will review it and change the report to “Negative” if they determine you are receiving ketamine for a legitimate reason. 

Consult Your Treating Clinic

Your ketamine infusion provider is your best resource for guidance and official documentation. Ask your clinician to provide a formal letter on clinic letterhead. This letter confirms your patient status, diagnosis, medication (ketamine), and treatment date range.

When to Contact Avesta

The Avesta Ketamine and Wellness team is here to assist you with any questions related to ketamine therapy, including its administrative aspects, such as drug testing documentation and timing.

We encourage you to reach out to our clinics in DC, Bethesda, Tysons, Norfolk, or Columbia if you have questions about the following:

• Requesting a formal treatment documentation letter to present to a medical review officer for an upcoming or recent drug test.
• Clarifying which specific drug panel your employer or ordering agency is using and whether ketamine is included.
• Inquiring about starting ketamine therapy and how we proactively manage the risk of complications with required drug screenings.

Please contact the Avesta ketamine clinic location nearest you in the DMV area to speak with a member of our team. We’ll help ensure you have all the information to navigate the drug testing process with confidence.

FAQs About Drug Testing for Ketamine

Will ketamine appear on my employment drug test?

Answer: Highly unlikely. Standard workplace drug tests (5-panel, 10-panel, 12-panel, and DOT-mandated tests) do not automatically screen for ketamine. Detection only happens if the employer or organization orders an expanded toxicology panel that includes ketamine and its metabolites.

Does ketamine show up as an opioid or PCP on drug tests? 

Answer: Highly unlikely. Specialized lab tests, such as gas chromatography and mass spectroscopy testing (GC-MS), will accurately distinguish between ketamine, opioids, and PCP. Older tests or generic urine tests could theoretically create a false positive. However, a confirmatory GC/MS test will clarify the results.   

Will I get fired if a drug test detects ketamine in my system?

Answer: Not typically, if you have a valid reason and follow protocol. Federal law, specifically the Americans with Disabilities Act (ADA), often protects employees who use legally prescribed medications for a legitimate condition.

The Caveat: Termination risk may increase in safety-sensitive roles (e.g., DOT, heavy machinery, pilot) or security clearance jobs where the use of any potentially impairing drug (even prescribed) may violate regulations. Risk also increases if you fail to disclose the prescription to the MRO and are confirmed positive for illicit use. Additionally, evidence of impairment at work could warrant termination. 

Disclaimer: This article does not count as legal advice and may contain errors. Employment law varies by state and industry. Consult your company’s HR policy and an employment law attorney for specific legal advice regarding your situation.

Will I test positive for ketamine if I undergo Spravato therapy?

Answer: Yes, but only if the test screens for ketamine and its metabolites. Spravato (esketamine) is one of the two enantiomers that make up ketamine, and it will be detectable on a ketamine panel. Proactive disclosure with clinical documentation can help patients avoid risk.

How long does it take ketamine to leave my system?

Answer: Detection time depends on the test type, dosage, and frequency:

• Urine (Most Common): 3–10 days after a single dose, possibly up to 22–96 days for chronic/frequent use.
• Blood/Saliva: Typically only hours. Perhaps up to 24 hours. 
• Saliva: Mostly undetectable within 4-6 hours post-administration.
• Hair: Up to several (4) months (rarely used for employment screening).